Member Info for kilman

That's an extract from their contract from June 2022 contract.
Nothing knew here and I like the way only a small section is show but this is in relation to sharing costs.
Full document https://contracts.justia.com/companies/vaxart-inc-6954/contract/249500/

First time since Feb 2nd 2022!

Or aliens arrive and give us the vaccines/antivirals for all viruses and diseases!

Short,
You are going on about electricity/gas bills(!!) but I've not heard you mention anything of the almost £17m in contract wins this month!

Thank you for your words of advice for us. We can take them on board although we are big boys and girls who can make up our own minds!
Can you now go to one of the other stocks you short and proclaim the same there? I think we have heard enough.

I've had them showing in my nominee account(Davy) since just after we were informed but they are still restricted.

Yes it is. I just checked 1/2 year results and it states
"Targeting revenues in the region of £50m for 2022 in non-COVID-19 work"

Is this 50m(excl any government Covid contracts)?

Only getting to read what stt1 quoted earlier.
He posts a link to a study carried out by the NIAID (US state agency) that was on behalf of of a number of hospitals.

Now I'm not saying that there are not competitors out there to OO but this link doesn't show it.
The NIAID is not available for big pharma to use!!

moniman,
Realistically that can only happen with a buyout of the company.

Bazza, I think at the last investor meeting he said late 2021/early 2022 for DIM.
Not great but flagged previously.

https://www.economist.com/science-and-technology/2021/09/11/why-scientists-are-deliberately-infecting-volunteers-with-covid-19

too true Moniman, the extra day delay was because Leo had to rummage through the recycle bin to find said fag packet!

"yes he emphasised this point, saying profitable service companies should pay an annual dividend. Don't expect a massive one - maybe 1p a share, which equates to just under £7m."

I think the broker forecasts for EBITDA for the year is around 6m to 7m, so IMHO there is no way they would pay out 1p divi later this year. If one is paid it won't be more than 0.3p to 0.5p/share. But hey maybe interims show a 10m EBITA ytd!!!

Info on Trial (which has already commenced as CF states)
https://clinicaltrials.gov/ct2/show/NCT04913610

Bronxville,
You are not even reading the links you are posting. That one for 2009 was for treating African trypanosomiasis (HAT).
This trial is for Onchocerciasis Disease ,
https://dndi.org/press-releases/2019/dndi-receives-29-million-fast-track-development-drugs-help-eliminate-sleepingsickness-riverblindness/

Well they have €14.2m from the Bill & Melinda Gates Foundation for work on a cure for River Blindness (Onchocerciasis).
So stupid to say anything about how Not for Profit would mean a lesser revenue.

Same for me with DavySelect. Makes my ORPH average look better :)

Mike, if you bought your shares through the IPO then they are tradeable on Monday once in account.

Its the ones you got for 'free' because you owned OO that are untradeable for 9mths.

Decent interview. Hopefully once we break 27p the SP we will pick up some momentum

Shows confidence in the company. Easier to buy shares in the company if the head man is putting 300k of his own cash in.